Table 1 Baseline subject characteristics

From: Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women

  Units Mean s.d. Range
Age Years 44.7 13.2 21–69
Weight kg 92.7 15.3 67.9–129.1
Waist circumference cm 99.4 11.1 76.0–125.5
BMI kg/m2 35.0 5.5 26.2–47.6
DXA fat mass kg 44.0 12.4 23.5–71.2
DXA abdominal fat kg 6.7 2.8 2.2–14.4
Total cholesterol mmol/l 5.5 1.1 3.4–9.2
LDL cholesterol mmol/l 3.5 1.0 1.3–6.1
HDL cholesterol mmol/l 1.4 0.3 0.7–2.3
Triglycerides mmol/l 1.71 0.83 0.5–5.2
Systolic blood pressure mm Hg 135.4 20.2 95.5–205.5
Diastolic blood pressure mm Hg 74.1 9.8 51.5–105.5
Sialic acid mmol/l 2.28 0.28 1.69–2.88
CRP mg/l 5.00 4.54 0.56–23.38
Adiponectin μg/ml 12.0 6.5 3.0–40.2
TNF-α pg/ml 2.48 2.80 0.07–18.93
IL6 pg/ml 3.61 3.30 0.31–21.68
Leptin ng/ml 27.07 15.13 0.88–61.76
HbA1c % 5.6 0.6 4.4–7.1
Fasting glucose mmol/l 5.8 0.7 4.3–8.0
Fasting insulin pmol/l 85.0 41.0 22.6–231.0
HOMA μU/mmol/l 3.13 1.76 0.74–9.56
AUC insulin pmol/l/120 min 55 696 31 155 16 170–171 570
AUC glucose mmol/l/120 min 62.9 39.0 12.9–265.0
  1. n=93 unless indicated otherwise.
  2. Abbreviations: AUC, area under the curve, BMI, body mass index; CRP, C-reactive protein; DXA, dual X-ray absorptiometry; HbA1c, Glycated haemoglobin; HOMA, homeostasis model assessment method; IL6, Interleukin-6; TNF-α, tumour necrosis factor-α.